SRX Global announced preliminary balance sheet results following its acquisition of EMJX and a 1-for-60 reverse stock split, reporting an estimated net asset value of approximately $60 million, or $3.07 per common share, as of June 30, 2026. The company held about $40 million in cash and more than $15 million in short-term investments, with no debt outstanding, and now has roughly 19.5 million shares outstanding on a post-split basis. CEO Kent Cunningham stated that the elimination of debt and completion of the EMJX acquisition have positioned SRX with one of the strongest balance sheets in its history, and management does not anticipate the need for an additional capital raise in the near term. SRX outlined a disciplined capital allocation framework including maintaining financial flexibility, optimizing treasury returns through a diversified fixed-income portfolio, reinvesting in Halo to drive product innovation and growth, and pursuing strategic investments and acquisitions. SRXH closed Wednesday's trading at $1.97, up 45.93%, and during overnight trading the stock was at $2.11, up 7.11%.
SRx Health Solutions Inc.SRX Global (SRx Health Solutions) reports strong balance sheet with $40M cash, no debt, and $3.07 NAV per share, eliminating need for near-term capital raise.
Halo Microelectronics Co. Ltd. A